Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.

Bibliographic Details
Main Author: PLOS ONE Staff
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4529244?pdf=render
_version_ 1819092877059293184
author PLOS ONE Staff
author_facet PLOS ONE Staff
author_sort PLOS ONE Staff
collection DOAJ
first_indexed 2024-12-21T23:02:35Z
format Article
id doaj.art-5262d714c8e14e11b100fd7d595bb134
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T23:02:35Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5262d714c8e14e11b100fd7d595bb1342022-12-21T18:47:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01108e013554710.1371/journal.pone.0135547Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.PLOS ONE Staffhttp://europepmc.org/articles/PMC4529244?pdf=render
spellingShingle PLOS ONE Staff
Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
PLoS ONE
title Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
title_full Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
title_fullStr Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
title_full_unstemmed Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
title_short Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
title_sort correction a lead in with silibinin prior to triple therapy translates into favorable treatment outcomes in difficult to treat hiv hepatitis c coinfected patients
url http://europepmc.org/articles/PMC4529244?pdf=render
work_keys_str_mv AT plosonestaff correctionaleadinwithsilibininpriortotripletherapytranslatesintofavorabletreatmentoutcomesindifficulttotreathivhepatitisccoinfectedpatients